Abstract: A method and system for managing database is disclosed, which is capable of simultaneously performing a data selection procedure and a data click-count update procedure when specific data is selected, the method comprising receiving and analyzing a query in which both a fetch request for a record included in a specific database table and an update request for at least one of columns included in the record are defined together; generating an execution plan to execute the analyzed query; and executing the execution plan by fetching the record and updating at least one of the columns according to the execution plan.

Abstract: Improved G-rich oligonucleotide (GRO) aptamers specific to nucleolin, a method of preparing the aptamers, and a use of the aptamers for diagnosing and/or treating a nucleolin-associated disease, are provided.

Abstract: A plasma display panel (PDP) comprises: a front substrate and a rear substrate which face each other; and a barrier wall which is interposed between the front substrate and the rear substrate, which includes base portions arranged on either side of a main discharge space, and protruding portions protruding on the base portions, respectively, and which defines stepped spaces on either side of the main discharge space. The stepped spaces are formed according to stepped surfaces formed by the base portions and the protruding portions. The PDP further comprises a pair of a scan electrode and a sustain electrode which generate a mutual discharge through the main discharge space. A channel space is defined by outer walls of the protruding portions on either side of the main discharge space, and an external light absorbing layer covers the channel space.

Abstract: A method for preparing amino linker oligonucleotides is provided. More specifically, a method of preparing 5?-amino-linker oligonucleotides comprising the steps of: introducing an amino linker having a protecting group into the 5? terminus of an oligonucleotide; and removing the protecting group from the amino linker oligonucleotide by contacting with acetic acid and 2,2,2-trifluoroethanol is provided. The amino protecting group is efficiently removed from the amino linker oligonucleotides, and thereby achieving a high yield of the amino linker oligonucleotides.

Abstract: A plasma display panel is disclosed. The plasma display panel has discharge cells which each have a range of widths between the first substrate and the second substrate. In addition, the discharge spaces are separated by non-discharge spaces having heights which are less than the heights of the discharge spaces.

Abstract: A plasma display panel is disclosed. The plasma display panel has discharge cells which each have a range of widths between the first substrate and the second substrate. In addition, the discharge spaces are separated by non-discharge spaces having heights substantially the same as the heights of the discharge spaces.

Abstract: An LCD device is disclosed. The LCD device includes a liquid crystal panel configured to include a bonding portion formed in its one edge, pluralities of gate and data lines arranged on it, and pixel regions defined by the gate and data lines. The bonding portion includes: first metal patterns formed away from each other and on a substrate of the liquid crystal panel; a gate insulation film and a protective layer sequentially formed to cover the first metal patterns; and a second metal pattern formed on the protective layer and electrically connected to the first metal patterns partially exposed by contact holes which are formed by partially etching the gate insulation film and protective layer.

Abstract: A plasma display panel (PDP) includes: a front substrate facing a rear substrate; first and second discharge enhancement layers disposed between the front and rear substrates and arranged on both sides of a main discharge space; first and second barrier ribs respectively formed on the first and second discharge enhancement layers and defining first and second asymmetric stepped spaces along with the first and second discharge enhancement layers; a scan electrode and a common electrode inducing a mutual discharge in the main discharge space; an address electrode generating an address discharge along with the scan electrode and extending in a direction to intersect the scan electrode; a phosphor layer formed in at least the main discharge space; and a discharge gas filled in the main discharge space and the first and second stepped spaces. Accordingly, the PDP having high efficiency may operate with low power and obtain high luminous brightness.

Abstract: A plasma display panel (PDP) comprises: a front substrate and a rear substrate which face each other; and a barrier wall which is interposed between the front substrate and the rear substrate, which includes base portions arranged on either side of a main discharge space, and protruding portions protruding on the base portions, respectively, and which defines stepped spaces on either side of the main discharge space. The stepped spaces are formed according to stepped surfaces formed by the base portions and the protruding portions. The PDP further comprises a pair of a scan electrode and a sustain electrode which generate a mutual discharge through the main discharge space. A channel space is defined by outer walls of the protruding portions on either side of the main discharge space, and an external light absorbing layer covers the channel space.

Abstract: Improved G-rich oligonucleotide (GRO) aptamers specific to nucleolin, a method of preparing the aptamers, and a use of the aptamers for diagnosing and/or treating a nucleolin-associated disease, are provided.

Abstract: A plasma display panel is disclosed. The plasma display panel has discharge cells which each have a range of widths between the first substrate and the second substrate. In addition, the discharge spaces are separated by non-discharge spaces having heights which are less than the heights of the discharge spaces.

Abstract: A plasma display panel is disclosed. The plasma display panel has discharge cells which each have a range of widths between the first substrate and the second substrate. In addition, the discharge spaces are separated by non-discharge spaces having heights substantially the same as the heights of the discharge spaces.

Abstract: A method for preparing amino linker oligonucleotides is provided, wherein an amino protecting group is efficiently removed from the amino linker oligonucleotides protected by the protecting group, and thereby achieving a high yield of the amino linker oligonucleotides.

Abstract: A method and system for managing database is disclosed, which is capable of simultaneously performing a data selection procedure and a data click-count update procedure when specific data is selected, the method comprising receiving and analyzing a query in which both a fetch request for a record included in a specific database table and an update request for at least one of columns included in the record are defined together; generating an execution plan to execute the analyzed query; and executing the execution plan by fetching the record and updating at least one of the columns according to the execution plan.

Abstract: Disclosed herein is a dental scaler for removing accumulated deposits from the teeth, having a low manufacturing cost so as to be widely used at home. The dental scaler includes a first casing adapted to serve a grip; a power supply-receiving section and a motor installed at the inside of a first casing serving as a grip, wherein the power supply-receiving section is adapted to contain a power supply device therein and a rotating speed of the motor is adjustable by a first switch. A vibrator is eccentrically installed at a driving shaft of the motor to be selectively in electrical contact with a second switch for connecting or disconnecting a power of an electromagnet An electromagnet-receiving section is formed at the front end portion of the first casing, for containing the electromagnet therein.

Abstract: Composition for the sustained release of a biologically active agent in vivo. The composition comprises microcarriers containing a first solid-phase biocompatible material and a biologically active agent, wherein said microcarriers sustain the in vivo release of the biologically active agent. The composition also contains particles of a second biocompatible solid-phase material wherein the second solid-phase material further sustains the in vivo release of the biologically active agent.The invention also relates to a method for sustaining effective serum levels of a biologically active agent in a subject, including forming an injectable dose containing an effective amount of a biologically active agent, wherein the agent is contained in a microcarrier, with a release-period sustaining amount of a solid-phase material. The method further includes administering the injectable dose to the subject.